No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Mannitol is predominantly eliminated via renal glomerular filtration and does not undergo active renal transport. There is little potential for an interaction with emtricitabine and tenofovir due to competition for active renal elimination pathways.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking